CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA
Clinical trials for CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA trials appear
Sign up with your email to follow new studies for CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo pill aims for deep remission in blood cancer, hoping patients can stop treatment
Disease control Recruiting nowThis study is testing whether adding a pill called ASTX727 to the standard drug dasatinib works better for people newly diagnosed with a slow-growing type of blood cancer called chronic myeloid leukemia (CML). The goal is to achieve a very deep remission, where the cancer is near…
Matched conditions: CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Could your personality predict if You'll take your cancer pills?
Knowledge-focused Recruiting nowThis study aims to understand if a patient's personality is linked to how consistently they take their oral medication for chronic myeloid leukemia (CML). Researchers will recruit 75 people with CML who are on specific cancer drugs. Participants will answer questionnaires about t…
Matched conditions: CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA
Sponsor: University of California, Irvine • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:41 UTC